Type | Filing | Company | SIC | Rel | IRS # | State of INC | FY End | Mailing address | Former | Filing Vals | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
subject company |
|
Innoviva, Inc.
Cik: 0001080014 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE, CA, 94005 ![]() |
2834 - Pharmaceutical Preparations |
943265960 |
![]() |
1231 |
2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE, CA, 94005 ![]() |
|
|
|||||||||||||
filed by |
|
Sarissa Capital Management LP
Cik: 0001577524 660 STEAMBOAT ROAD GREENWICH, CT, 06830 ![]() |
900924432 |
![]() |
1231 |
660 STEAMBOAT ROAD GREENWICH, CT, 06830 ![]() |
|
DFAN14A 0001193125-17-088708
Definitive additional proxy soliciting materials filed by non-management including Rule 14
- filing date
- March 20, 2017
- effectiveness date
- March 20, 2017
- accepted date
- March 20, 2017
- accession number
- 0001193125-17-088708
- type
- DFAN14A
- public document count
- 1
Key documents and exhibits
Link: | Type | Id | filename |
---|---|---|---|
DFAN14A | DFAN14A | 1 | d327426ddfan14a.htm |